Location: United States, Minnesota, Minneapolis
Employees: 1-10
Total raised: $5M
Founded date: 2016
Funding Rounds 1
| Date | Series | Amount | Investors |
| 22.04.2024 | Seed | $5M | - |
Mentions in press and media 9
| Date | Title | Description |
| 09.05.2024 | Pelvital Appoints Dr. Wanda Filer To Its Board of Directors | Flyte by Pelvital Dr. Filer's history of advocacy for transformative care will help Pelvital in its mission to revolutionize the standard of care for UI EAGAN, Minn., May 9, 2024 /PRNewswire-PRWeb/ -- Pelvital, the women's health MedTech co... |
| 23.04.2024 | Pelvital Secures $5M to Revolutionize Women's Health | Pelvital USA, Inc., a trailblazer in women's health, has closed a $5M seed-plus funding round to propel their groundbreaking treatment for stress urinary incontinence (SUI). Led by Boomerang Ventures, this investment will turbocharge the co... |
| 23.04.2024 | OB/GYN med-tech company Pelvital finishes seed funding round at $5M total | - |
| 22.04.2024 | Pelvital Closes $5M in Expand Stress Urinary Incontinence Treatment | What You Should Know: – Pelvital USA, Inc., a leading women’s health innovator, has announced the successful closing of an oversubscribed $5M seed-plus funding round. The investment round was led by Boomerang Ventures with new investors inc... |
| 22.04.2024 | Pelvital Announces Additional $2.32 Million Seed Plus Funding Boost For Flyte® | Flyte by Pelvital Pelvital Raises A Total of $5 Million In Seed Funding Spearheaded By Boomerang Ventures To Address Underserved Pelvic Health Issues EAGAN, Minn., April 22, 2024 /PRNewswire-PRWeb/ -- Pelvital USA, Inc., a leading innovator... |
| 20.08.2020 | Pelvital Announces FDA Clearance of Flyte™, In-Home Pelvic Floor Muscle Treatment for Stress Urinary Incontinence | MINNEAPOLIS–(BUSINESS WIRE)–August 20, 2020– Pelvital, a medical technology company focused on women’s health, announced it has received U.S. Food and Drug Administration (FDA) clearance for Flyte™, a first-of-its-kind, non-invasive, intrav... |
| - | Pelvital: Women’s Health Company Closes $2.32 Million | Pelvital, a leading women’s health company, announced the successful closing of an additional $2.32 million in its seed-plus funding round, closing the round out $500,000 oversubscribed at $5 million. The seed plus funding will be used to e... |
| - | Pelvital: Women’s Health Company Raises $2.68 Million | Pelvital – a leading innovator in women’s health – recently announced closing a $2.68 million seed funding round for Flyte, an accessible and clinically proven treatment for stress urinary incontinence (SUI) and weakened pelvic floor muscle... |
| - | Pelvital | “Flyte promotes cellular healing in pelvic floor muscles for lasting results. Flyte is fast, proven, safe, pelvic floor therapy for bladder control.” |